PF-06459988
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


PF-06459988
Target:
EGFRRelated Pathways:
Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||AngiogenesisPurity:
0.98Bioactivity:
PF-06459988 is a novel, effective, orally active, irreversible, and selective epidermal growth factor receptor (EGFR) mutant inhibitor. PF-06459988 has high efficiency and high affinity for EGFRs double mutants containing T790M, and has minimal activity against WT EGFR. PF-06459988 makes a candidate drug for the treatment of cancer.Smiles:
CO[C@H]1CN (C[C@@H]1COc1nc (Nc2cnn (C) c2) nc2[nH]cc (Cl) c12) C (=O) C=CMolecular Formula:
C19H22ClN7O3Molecular Weight:
431.88Shipping Conditions:
Cool packStorage Temperature:
-20°CCAS Number:
1428774-45-1
